Cardiol Therapeutics Inc. (TSX: CRDL) Stock Analysis & Fundamentals

CRDLCardiol Therapeutics Inc.

TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · cardiolrx.com

2.620CAD-2.96%Mkt Cap: 229.71M $P/E: —Today

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx,…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap229.71M $

Enterprise Value203.14M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-24.63M $

Revenue/Share—

Last Price2.620 CAD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees18

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-8.60

PEG—

EV/EBITDA-7.78

EV/Revenue—

P/S—

P/B12.61

EPS (TTM)-0.34

EPS (Forward)-0.30

52W Range

1.22595% of range2.700

52W High2.700 CAD

52W Low1.225 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-189.17%

ROA-143.18%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-17.37M $

CapEx (TTM)17.83K $

FCF Margin—

FCF Yield-4.91%

Net Debt-18.92M $

Net Debt/EBITDA0.72

Balance Sheet

Debt/Equity0.01

Current Ratio5.55

Quick Ratio5.01

Book Value/Sh0.2070 CAD

Cash/Share0.2230 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)6.000 CAD

Upside (mean)+129.0%

Target Range5.000 CAD – 7.000 CAD

CAD5.000+129.0% to meanCAD7.000

# Analysts2

Ownership

Shares Out.116.82M

Float97.81M

Insiders2.37%

Institutions25.91%

Short Interest

Short Ratio1.9d

Short % Float0.16%

Short % Out.0.16%

Shares Short183.67K

Short (prev mo.)172.46K

Technical

SMA 501.750 (+49.7%)

SMA 2001.598 (+64.0%)

Beta0.47

S&P 52W Chg18.16%

Avg Vol (30d)147.27K

Avg Vol (10d)275.26K

Technical Indicators

RSI (14)86.3

MACD0.2200

MACD Signal0.1372

MACD Hist.+0.0828

BB Upper2.547 CAD

BB Middle1.942 CAD

BB Lower1.338 CAD

BB Width62.21%

ATR (14)0.1381 CAD

Vol Ratio (20d)1.77x